喹诺酮及多重耐药预示自发性细菌性腹膜炎抗生素预防失败
这项前瞻性观察研究在德国三级中心纳入77例肝硬化需氟喹诺酮预防SBP的患者,基线MDRO定植率50.6%,预防期间35.1%出现新发MDRO,QR-GNB独立关联预防失败(HR 3.39)及SBP前死亡(SHR 6.47)。
要点
- 基线MDRO定植率高达50.6%,预防期间35.1%出现新发MDRO。
- QR-GNB独立预测预防失败(HR 3.39)及SBP前死亡(SHR 6.47)。
- 已知MDRO患者抗生素预防SBP效果可能较差,需定期筛查。
核心结论
- 已知MDRO患者中抗生素预防SBP效果可能较差。
- QR-GNB独立关联预防失败(HR 3.39,P=.045)及SBP前死亡(SHR 6.47,P=.034)。
研究设计与样本
- 前瞻性观察研究,纳入77例肝硬化需氟喹诺酮预防SBP患者,平均预防93天。
- 在德国大型三级参考中心招募随访,基线和第30、60、90、180天行微生物与临床监测。
主要发现
- 基线MDRO定植39例(50.6%),预防期间新发MDRO 27例(35.1%)。
- 33例(42.9%)发生继发感染,其中MDRO感染14例(17.9%),新发/复发SBP 13例(16.9%)。
- 随访期间30例(39.0%)死亡。
- 有 vs 无任何MDRO(P=.009)、VRE(P=.008)、MDR-GNB(P=.016)、QR-GNB(P=.015)者预防期间SBP风险显著更高。
临床怎么用
- 对已知MDRO患者,应重新评估氟喹诺酮预防SBP的获益。
- 定期MDRO筛查有助于指导继发感染治疗并在选择喹诺酮耐药时重新评估预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The efficacy of antibiotic prophylaxis to prevent spontaneous bacterial peritonitis (SBP) in patients colonized with multidrug-resistant organisms (MDROs) is unknown. We evaluated the effectiveness of fluoroquinolone-based SBP prophylaxis in an era and area of frequent antibiotic resistance. METHODS: This is a prospective observational study in patients with liver cirrhosis and an indication for fluoroquinolone-based prophylaxis of SBP. Patients were recruited and followed in a large German tertiary reference center with comprehensive microbiological and clinical monitoring performed at baseline and after 30, 60, 90, and 180 days of prophylaxis. RESULTS: Overall, 77 patients received antibiotic prophylaxis for an average of 93 days. Baseline prevalence of colonization with MDROs was high (N = 39, 50.6%). At least one de novo MDRO was detected in 27 patients (35.1%) during antibiotic prophylaxis; 33 patients (42.9%) developed secondary infections, including 14 cases (17.9%) of infections with MDROs, and 13 cases (16.9%) of de novo/recurrent SBP. Thirty patients (39.0%) died during follow-up. Significantly higher risks of SBP development during antibiotic prophylaxis were observed for patients with versus without any apparent MDROs (P = .009), vancomycin-resistant enterococci (P = .008), multidrug-resistant gram-negative bacteria (P = .016), or quinolone-resistant gram-negative bacteria (QR-GNB) (P = .015). In competing risk analysis, QR-GNB were independently associated with prophylaxis failure (hazard ratio, 3.39; P = .045) and infections with QR-GNB were independently associated with death before SBP (subdistribution hazard risk, 6.47; P = .034). CONCLUSIONS: Antibiotic prophylaxis of SBP appears to be less efficient in patients with known MDROs. Regular MDRO screening seems to be useful to tailor treatment of secondary infections and re-evaluate antibiotic prophylaxis in case of selection of quinolone resistance.
引用
- Mücke MM, Mayer A, Kessel J, et al. Quinolone and Multidrug Resistance Predicts Failure of Antibiotic Prophylaxis of Spontaneous Bacterial Peritonitis. Clin Infect Dis. 2020. PMID: 31228250. doi:10.1093/cid/ciz540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。